loratadine 10 MG Oral Tablet [Tavist Non-Sedating]

RxNorm concept 404053, branded drug (sbd). Prescribable name: Tavist ND 10 MG 24HR Oral Tablet.

RxCUI: 404053
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/404053 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

loratadine 28889

Other names

Tavist Non-Sedating 10 MG Oral Tablet

Related concepts

loratadine 10 MG (SCDC, consists of)
loratadine 10 MG [Tavist Non-Sedating] (SBDC, consists of)
Oral Tablet (DF, has dose form)
Tavist Non-Sedating (BN, has ingredient)
loratadine 10 MG Oral Tablet (SCD, tradename of)

Linked data

NDCs

00067606310
00067606330

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 404053 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/404053 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 404053. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.